NEPAFENAC

NEPAFENAC was reported 3193 times

NEPAFENAC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CORNEAL EPITHELIUM DISORDER 9 0.2571
1 EMBOLIC PNEUMONIA 4 0.1905
2 GLAUCOMATOUS OPTIC NEUROPATHY 3 0.1500
3 ANTERIOR CHAMBER CRYSTALLISATION 1 0.1429
4 FIBRIN 6 0.1395
5 INFECTIOUS CRYSTALLINE KERATOPATHY 5 0.1351
6 ANTERIOR CAPSULE CONTRACTION 1 0.1250
7 CORNEAL HYPERTROPHY 1 0.1111
8 CILIARY ZONULAR DEHISCENCE 1 0.0909
9 AQUEOUS HUMOUR LEAKAGE 2 0.0833
10 ARTICULAR DISC DISORDER 3 0.0811
11 BULLOUS KERATOPATHY 1 0.0714
12 PSEUDOENDOPHTHALMITIS 7 0.0707
13 AQUEOUS FIBRIN 3 0.0588
14 CORNEAL IRRITATION 4 0.0500
15 DISORDER OF GLOBE 2 0.0488
16 CORNEAL EPITHELIUM DEFECT 28 0.0482
17 FLOPPY IRIS SYNDROME 17 0.0461
18 MALABSORPTION FROM APPLICATION SITE 7 0.0458
19 TOXIC ANTERIOR SEGMENT SYNDROME 43 0.0394
20 ANTERIOR CHAMBER FIBRIN 5 0.0388
21 CORNEAL INFILTRATES 12 0.0382
22 NEUROTROPHIC KERATOPATHY 2 0.0370
23 OCCUPATIONAL PROBLEM ENVIRONMENTAL 2 0.0339
24 IRIS ATROPHY 7 0.0338
25 CORNEAL ENDOTHELIITIS 3 0.0312
26 FIBROADENOMA OF BREAST 14 0.0311
27 CYSTOID MACULAR OEDEMA 58 0.0308
28 ANTERIOR CHAMBER FLARE 7 0.0300
29 CORNEAL SCAR 14 0.0278
30 CORNEAL THINNING 7 0.0272
31 CORNEAL OPACITY 37 0.0271
32 ANTERIOR CHAMBER INFLAMMATION 16 0.0269
33 CORNEAL EPITHELIOPATHY 1 0.0263
34 VITREOUS HAZE 4 0.0261
35 PUPILLARY DEFORMITY 2 0.0250
36 CORNEAL DECOMPENSATION 4 0.0248
37 ULCERATIVE KERATITIS 68 0.0248
38 MACULAR CYST 2 0.0238
39 CORNEAL OEDEMA 49 0.0218
40 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 14 0.0216
41 ANTERIOR CHAMBER CELL 15 0.0210
42 PUNCTATE KERATITIS 19 0.0207
43 ATRIAL APPENDAGE CLOSURE 1 0.0200
44 CORNEAL EROSION 10 0.0186
45 EYE OPERATION COMPLICATION 3 0.0183
46 OCULAR VASCULAR DISORDER 15 0.0182
47 PRODUCT DROPPER ISSUE 14 0.0178
48 CORNEAL PIGMENTATION 1 0.0175
49 CORNEAL PERFORATION 11 0.0174
50 ANTERIOR CHAMBER DISORDER 4 0.0174
51 ACQUIRED CARDIAC SEPTAL DEFECT 1 0.0169
52 CARBOXYHAEMOGLOBIN INCREASED 1 0.0167
53 BACTERIAL RHINITIS 1 0.0164
54 CORNEAL DISORDER 35 0.0159
55 HYPOPYON 13 0.0157
56 CORNEAL DEFECT 2 0.0152
57 CORNEAL ENDOTHELIAL CELL LOSS 1 0.0147
58 CORNEAL THICKENING 1 0.0147
59 CONJUNCTIVAL ULCER 2 0.0145
60 CORNEAL STRIAE 1 0.0141
61 CORNEAL INFECTION 3 0.0138
62 OPEN ANGLE GLAUCOMA 8 0.0130
63 MACULAR OEDEMA 70 0.0125
64 INTRAOCULAR LENS IMPLANT 6 0.0121
65 OCULAR HYPERTENSION 23 0.0118
66 INJURY CORNEAL 6 0.0115
67 FLAT ANTERIOR CHAMBER OF EYE 2 0.0112
68 SCLERAL DISORDER 3 0.0111
69 CUTIS LAXA 3 0.0110
70 LARYNGEAL DISCOMFORT 7 0.0110
71 CILIARY HYPERAEMIA 1 0.0105
72 RETINOPATHY PROLIFERATIVE 2 0.0103
73 CORNEAL EXFOLIATION 1 0.0098
74 GLARE 5 0.0097
75 IMPLANTATION COMPLICATION 2 0.0096
76 OCULAR TOXICITY 10 0.0091
77 CORNEAL TOXICITY 1 0.0090
78 POSTERIOR CAPSULE OPACIFICATION 3 0.0087
79 ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST POSITIVE 1 0.0084
80 CORNEAL DEGENERATION 2 0.0083
81 CONJUNCTIVAL EROSION 1 0.0083
82 EYE PAIN 455 0.0081
83 GLAUCOMA SURGERY 2 0.0078
84 CORNEAL TRANSPLANT 6 0.0077
85 RETINITIS PIGMENTOSA 2 0.0076
86 INTRAOCULAR PRESSURE DECREASED 4 0.0076
87 LIQUID PRODUCT PHYSICAL ISSUE 55 0.0075
88 EYE COMPLICATION ASSOCIATED WITH DEVICE 2 0.0074
89 CENTRAL SEROUS CHORIORETINOPATHY 5 0.0073
90 RETINAL OEDEMA 14 0.0073
91 CORNEAL ABRASION 10 0.0073
92 COLON DYSPLASIA 2 0.0070
93 ADDISON'S DISEASE 1 0.0069
94 HYPOAESTHESIA EYE 4 0.0068
95 CATARACT CORTICAL 1 0.0067
96 BENIGN NEOPLASM OF ADRENAL GLAND 1 0.0067
97 ENDOPHTHALMITIS 40 0.0067
98 CONJUNCTIVAL SCAR 1 0.0066
99 PUPILLARY DISORDER 4 0.0066
100 FOREIGN BODY SENSATION IN EYES 41 0.0064
101 CATARACT OPERATION COMPLICATION 3 0.0059
102 NON-INFECTIOUS ENDOPHTHALMITIS 5 0.0059
103 IRIS ADHESIONS 3 0.0058
104 PTERYGIUM 2 0.0058
105 ARTERIOVENOUS FISTULA OCCLUSION 1 0.0057
106 ACQUIRED DIAPHRAGMATIC EVENTRATION 2 0.0056
107 OESOPHAGEAL FOOD IMPACTION 3 0.0054
108 BLOOD GROWTH HORMONE INCREASED 3 0.0054
109 ACANTHAMOEBA INFECTION 1 0.0053
110 CONJUNCTIVAL DISORDER 2 0.0052
111 PRODUCT PHYSICAL CONSISTENCY ISSUE 29 0.0052
112 HYPERPARATHYROIDISM SECONDARY 13 0.0052
113 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 1 0.0051
114 DEAFNESS PERMANENT 1 0.0051
115 INTRAOCULAR PRESSURE INCREASED 64 0.0050
116 ELECTRIC SHOCK SENSATION 14 0.0050
117 IRITIS 15 0.0049
118 OROPHARYNGEAL PLAQUE 2 0.0049
119 CATARACT SUBCAPSULAR 3 0.0049
120 CONJUNCTIVAL OEDEMA 5 0.0049
121 RENAL COLIC 11 0.0049
122 HYPOTONY OF EYE 2 0.0048
123 HAEMOLYTIC URAEMIC SYNDROME 11 0.0047
124 AUTOINFLAMMATORY DISEASE 1 0.0047
125 ANGIOMYOLIPOMA 1 0.0047
126 HEART VALVE OPERATION 2 0.0046
127 KERATITIS 14 0.0046
128 LENTICULAR OPACITIES 2 0.0046
129 COLORECTAL ADENOCARCINOMA 1 0.0045
130 ACUTE LEFT VENTRICULAR FAILURE 3 0.0045
131 MACULAR FIBROSIS 3 0.0044
132 EYE INFLAMMATION 42 0.0044
133 VITRITIS 8 0.0043
134 NEPHROGENIC ANAEMIA 20 0.0043
135 SACROILIITIS 8 0.0042
136 LACRIMATION DECREASED 2 0.0042
137 RETINAL VASCULITIS 5 0.0042
138 VITREOUS DISORDER 2 0.0041
139 HYPERAEMIA 8 0.0041
140 DIABETIC RETINAL OEDEMA 2 0.0039
141 EYE COLOUR CHANGE 4 0.0039
142 CHEST WALL HAEMATOMA 1 0.0039
143 HYPHAEMA 2 0.0038
144 CONJUNCTIVITIS VIRAL 1 0.0038
145 CHOROIDAL EFFUSION 3 0.0037
146 SUBRETINAL FLUID 4 0.0037
147 VITREOUS FLOATERS 36 0.0037
148 PRODUCT CONTAINER ISSUE 31 0.0036
149 VISUAL ACUITY TESTS ABNORMAL 2 0.0036
150 SEROUS RETINAL DETACHMENT 3 0.0036
151 ASBESTOSIS 1 0.0035
152 UVEITIS 47 0.0035
153 EYE INJURY 10 0.0033
154 EYE DISCHARGE 34 0.0033
155 CORNEAL LESION 1 0.0032
156 FOREIGN BODY IN EYE 3 0.0031
157 SCLERITIS 5 0.0031
158 CHORIORETINITIS 2 0.0031
159 DUST ALLERGY 3 0.0031
160 CATARACT OPERATION 18 0.0030
161 ABNORMAL SENSATION IN EYE 13 0.0030
162 CATARACT NUCLEAR 2 0.0030
163 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
164 SUTURE RUPTURE 2 0.0029
165 PRODUCT CONTAINER SEAL ISSUE 5 0.0029
166 THERAPEUTIC RESPONSE DELAYED 8 0.0029
167 OCULAR DISCOMFORT 32 0.0028
168 INTRAOCULAR PRESSURE TEST ABNORMAL 2 0.0028
169 CHORIORETINOPATHY 4 0.0028
170 VISUAL ACUITY REDUCED 93 0.0028
171 GALLBLADDER ENLARGEMENT 3 0.0028
172 TREATMENT FAILURE 230 0.0028
173 EYELID MARGIN CRUSTING 8 0.0028
174 CERVICAL CORD COMPRESSION 1 0.0028
175 SEBORRHOEIC KERATOSIS 4 0.0028
176 VITAMIN B12 DEFICIENCY 11 0.0027
177 CENTRAL OBESITY 2 0.0027
178 BLINDNESS UNILATERAL 38 0.0027
179 CORNEAL DEPOSITS 2 0.0027
180 CHOROIDITIS 1 0.0027
181 HALO VISION 3 0.0027
182 BLADDER PERFORATION 1 0.0026
183 KERATOPATHY 4 0.0025
184 CONJUNCTIVAL HYPERAEMIA 9 0.0025
185 RENAL HAEMANGIOMA 2 0.0025
186 REACTION TO PRESERVATIVES 2 0.0025
187 EYE OEDEMA 6 0.0024
188 CARDIAC VENTRICULAR DISORDER 1 0.0024
189 GIANT CELL ARTERITIS 2 0.0024
190 CARDITIS 1 0.0024
191 VITREOUS OPACITIES 2 0.0024
192 GLAUCOMA 45 0.0023
193 RETINAL DEGENERATION 3 0.0023
194 MACULAR HOLE 3 0.0022
195 CATARACT 131 0.0022
196 ALLERGY TO PLANTS 1 0.0022
197 RETINAL EXUDATES 2 0.0021
198 BLOOD CREATINE ABNORMAL 1 0.0021
199 RETINAL DETACHMENT 19 0.0021
200 CONJUNCTIVITIS ALLERGIC 3 0.0020
201 PHOTOPHOBIA 38 0.0020
202 COMPLICATIONS OF TRANSPLANT SURGERY 1 0.0020
203 PNEUMONIA PSEUDOMONAL 3 0.0020
204 EYE OPERATION 9 0.0020
205 VARICOSE VEIN 10 0.0019
206 VASCULITIS 22 0.0019
207 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
208 COATING IN MOUTH 1 0.0019
209 NIGHT BLINDNESS 3 0.0019
210 EYE IRRITATION 107 0.0019
211 VITREOUS DETACHMENT 4 0.0018
212 SUPERFICIAL INJURY OF EYE 2 0.0018
213 DRY AGE-RELATED MACULAR DEGENERATION 2 0.0018
214 EXPOSURE TO SARS-COV-2 3 0.0018
215 BURNOUT SYNDROME 1 0.0018
216 PRODUCT COLOUR ISSUE 9 0.0018
217 SERONEGATIVE ARTHRITIS 2 0.0017
218 RETINITIS 3 0.0017
219 THERAPY PARTIAL RESPONDER 26 0.0017
220 REBOUND ACID HYPERSECRETION 5 0.0017
221 RETINAL TEAR 4 0.0016
222 BACILLUS INFECTION 1 0.0016
223 VISION BLURRED 213 0.0015
224 DACRYOSTENOSIS ACQUIRED 2 0.0015
225 RETINAL DISORDER 4 0.0015
226 PRODUCT PACKAGING ISSUE 14 0.0015
227 OCULAR HYPERAEMIA 68 0.0014
228 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 2 0.0014
229 RETINAL VEIN OCCLUSION 4 0.0014
230 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 1 0.0014
231 PRODUCT PACKAGE ASSOCIATED INJURY 3 0.0013
232 CHOLANGITIS ACUTE 1 0.0013
233 ASTIGMATISM 2 0.0013
234 POST PROCEDURAL COMPLICATION 25 0.0013
235 ASPIRATION PLEURAL CAVITY 1 0.0013
236 EYELID DISORDER 3 0.0013
237 NEURITIS 2 0.0013
238 EYELID OEDEMA 15 0.0013
239 PRODUCT DEPOSIT 2 0.0013
240 EYELIDS PRURITUS 4 0.0013
241 ENTHESOPATHY 2 0.0013
242 BLEPHARITIS 5 0.0012
243 CARTILAGE ATROPHY 1 0.0012
244 PRODUCT ADMINISTRATION ERROR 25 0.0012
245 OPTIC ATROPHY 2 0.0012
246 END STAGE RENAL DISEASE 22 0.0012
247 ARTHROPOD STING 2 0.0012
248 EYE HAEMORRHAGE 16 0.0012
249 CULTURE POSITIVE 1 0.0012
250 DIABETIC RETINOPATHY 4 0.0012
251 CHOROIDAL NEOVASCULARISATION 1 0.0012
252 ALLERGIC SINUSITIS 1 0.0012
253 OCULAR ICTERUS 5 0.0012
254 AXIAL SPONDYLOARTHRITIS 1 0.0011
255 EYE DISORDER 37 0.0011
256 AORTIC VALVE STENOSIS 2 0.0011
257 BLOOD MAGNESIUM INCREASED 1 0.0011
258 ESSENTIAL HYPERTENSION 2 0.0011
259 CONTRAST MEDIA ALLERGY 2 0.0011
260 ASTHENOPIA 6 0.0011
261 ORAL DISORDER 8 0.0011
262 COLOUR BLINDNESS 1 0.0011
263 VITREOUS HAEMORRHAGE 3 0.0011
264 METAMORPHOPSIA 2 0.0011
265 EOSINOPHILIC OESOPHAGITIS 3 0.0011
266 DRUG TOLERANCE DECREASED 3 0.0011
267 BRAIN STEM HAEMORRHAGE 1 0.0011
268 MEDICATION RESIDUE PRESENT 5 0.0010
269 CORRECTIVE LENS USER 1 0.0010
270 CONCOMITANT DISEASE PROGRESSION 2 0.0010
271 PRODUCT USE COMPLAINT 16 0.0010
272 VISUAL IMPAIRMENT 125 0.0010
273 HEMIPARESIS 17 0.0010
274 BONE MARROW DISORDER 3 0.0010
275 RETINAL HAEMORRHAGE 7 0.0010
276 BREAST ABSCESS 1 0.0010
277 IMPAIRED HEALING 32 0.0010
278 EYE SWELLING 36 0.0010
279 CONSCIOUSNESS FLUCTUATING 1 0.0010
280 SWELLING OF EYELID 6 0.0010
281 IRIDOCYCLITIS 3 0.0009
282 PHOTOPSIA 6 0.0009
283 BURNS THIRD DEGREE 1 0.0009
284 CHRONIC KIDNEY DISEASE 72 0.0009
285 BONE DEMINERALISATION 1 0.0009
286 PRODUCT DISPENSING ISSUE 4 0.0009
287 PRODUCT RESIDUE PRESENT 5 0.0009
288 MYOPATHY 8 0.0009
289 OSTEOPENIA 14 0.0009
290 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
291 PRODUCT LOT NUMBER ISSUE 2 0.0009
292 URINARY TRACT DISORDER 4 0.0009
293 BENIGN NEOPLASM 1 0.0009
294 ARTERIAL HAEMORRHAGE 1 0.0009
295 VISUAL DISTURBANCE 5 0.0009
296 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
297 ENTEROCOCCAL INFECTION 4 0.0008
298 ASTHMATIC CRISIS 3 0.0008
299 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
300 BLINDNESS 33 0.0008
301 BLOOD PRESSURE SYSTOLIC ABNORMAL 2 0.0008
302 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
303 INSTILLATION SITE PAIN 2 0.0008
304 EYE INFECTION 9 0.0008
305 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
306 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
307 LACRIMATION INCREASED 23 0.0008
308 DRY EYE 38 0.0008
309 PRODUCT DELIVERY MECHANISM ISSUE 4 0.0007
310 ERYTHEMA OF EYELID 4 0.0007
311 SKIN WRINKLING 2 0.0007
312 CARBON DIOXIDE INCREASED 1 0.0007
313 CLUSTER HEADACHE 1 0.0007
314 TENOSYNOVITIS 2 0.0007
315 MACULE 2 0.0007
316 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
317 CULTURE URINE POSITIVE 1 0.0007
318 BODY TEMPERATURE DECREASED 7 0.0007
319 RESPIRATORY SYMPTOM 2 0.0007
320 CEREBELLAR HAEMORRHAGE 1 0.0007
321 VISUAL FIELD DEFECT 5 0.0007
322 EYELID PTOSIS 7 0.0007
323 BLINDNESS TRANSIENT 5 0.0007
324 ANKLE OPERATION 1 0.0007
325 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
326 MULTIPLE-DRUG RESISTANCE 2 0.0006
327 RENAL CYST 5 0.0006
328 LOOSE TOOTH 2 0.0006
329 AORTIC VALVE DISEASE 1 0.0006
330 ACUTE LEUKAEMIA 1 0.0006
331 FRUSTRATION TOLERANCE DECREASED 5 0.0006
332 POOR QUALITY DRUG ADMINISTERED 4 0.0006
333 BRADYARRHYTHMIA 1 0.0006
334 CORONAVIRUS INFECTION 4 0.0006
335 THERAPEUTIC AGENT TOXICITY 2 0.0006
336 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
337 ECONOMIC PROBLEM 9 0.0006
338 SENSATION OF FOREIGN BODY 5 0.0006
339 MACULAR DEGENERATION 7 0.0006
340 INFLAMMATION 30 0.0006
341 BLOOD CHLORIDE INCREASED 1 0.0006
342 CAROTID ARTERY STENOSIS 2 0.0006
343 SENSITIVITY TO WEATHER CHANGE 3 0.0006
344 GLOSSITIS 2 0.0006
345 PRODUCT CONTAMINATION 2 0.0006
346 THERAPY NON-RESPONDER 25 0.0006
347 SCLERODERMA 2 0.0005
348 OPTIC NEURITIS 5 0.0005
349 HYPERKERATOSIS 3 0.0005
350 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
351 WOUND HAEMORRHAGE 2 0.0005
352 STREPTOCOCCAL INFECTION 3 0.0005
353 RETINOPATHY 2 0.0005
354 EYE PRURITUS 18 0.0005
355 PROTEIN TOTAL DECREASED 2 0.0005
356 ADRENAL DISORDER 1 0.0005
357 MUSCLE TWITCHING 12 0.0005
358 OESOPHAGEAL DISORDER 2 0.0005
359 FOOD ALLERGY 4 0.0005
360 OPTIC ISCHAEMIC NEUROPATHY 2 0.0005
361 REHABILITATION THERAPY 2 0.0005
362 CONVERSION DISORDER 1 0.0005
363 AUTOIMMUNE DISORDER 5 0.0005
364 COLOSTOMY 1 0.0005
365 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
366 POST PROCEDURAL INFECTION 4 0.0005
367 PRODUCT QUALITY ISSUE 66 0.0005
368 PIGMENTATION DISORDER 3 0.0005
369 MULTIPLE INJURIES 3 0.0005
370 BLEPHAROSPASM 3 0.0005
371 ATRIAL TACHYCARDIA 1 0.0005
372 CARDIOVASCULAR DISORDER 12 0.0005
373 DIVERTICULUM INTESTINAL 2 0.0005
374 DENTAL CARIES 5 0.0005
375 CALCINOSIS 1 0.0004
376 POST-TRAUMATIC STRESS DISORDER 3 0.0004
377 PRODUCT PHYSICAL ISSUE 9 0.0004
378 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
379 ABDOMINAL HERNIA 2 0.0004
380 JOINT EFFUSION 3 0.0004
381 CONJUNCTIVITIS 8 0.0004
382 RENAL FUNCTION TEST ABNORMAL 2 0.0004
383 FLANK PAIN 4 0.0004
384 SEASONAL ALLERGY 6 0.0004
385 CONTRAST MEDIA REACTION 1 0.0004
386 DIPLOPIA 11 0.0004
387 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
388 RENAL FAILURE 55 0.0004
389 NOCTURIA 5 0.0004
390 CHOKING 8 0.0004
391 RENAL INJURY 12 0.0004
392 VEIN DISORDER 2 0.0004
393 BRAIN ABSCESS 1 0.0004
394 MUSCLE ATROPHY 5 0.0004
395 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
396 ANGLE CLOSURE GLAUCOMA 1 0.0004
397 EAR DISCOMFORT 4 0.0004
398 BLOOD CHLORIDE DECREASED 1 0.0004
399 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
400 ACTINIC KERATOSIS 1 0.0004
401 PELVIC FRACTURE 3 0.0004
402 SCRATCH 4 0.0004
403 TRICUSPID VALVE INCOMPETENCE 3 0.0004
404 GINGIVAL PAIN 3 0.0004
405 HIP FRACTURE 12 0.0004
406 BLOOD SODIUM INCREASED 1 0.0004
407 BLOOD PHOSPHORUS INCREASED 1 0.0004
408 ESCHERICHIA INFECTION 3 0.0004
409 BLOOD PRESSURE DECREASED 24 0.0004
410 EXPIRED PRODUCT ADMINISTERED 12 0.0004
411 CHOLECYSTITIS INFECTIVE 1 0.0004
412 EPILEPSY 11 0.0004
413 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
414 PRODUCT LEAKAGE 2 0.0004
415 PERIORBITAL SWELLING 2 0.0004
416 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
417 BLOOD PRESSURE ABNORMAL 7 0.0004
418 CARDIAC VALVE DISEASE 2 0.0003
419 MUSCLE STRAIN 3 0.0003
420 BLOOD PRESSURE INCREASED 53 0.0003
421 COMA SCALE ABNORMAL 1 0.0003
422 MADAROSIS 4 0.0003
423 RALES 2 0.0003
424 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
425 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
426 GROIN PAIN 3 0.0003
427 RIB FRACTURE 7 0.0003
428 URINE ODOUR ABNORMAL 2 0.0003
429 DECREASED INTEREST 2 0.0003
430 PRODUCT DOSE OMISSION 22 0.0003
431 WRONG DRUG ADMINISTERED 3 0.0003
432 FACIAL PAIN 3 0.0003
433 CARDIAC PACEMAKER INSERTION 2 0.0003
434 CHOLELITHIASIS 11 0.0003
435 BLOOD CULTURE POSITIVE 1 0.0003
436 HEARING IMPAIRED 2 0.0003
437 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
438 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
439 APHASIA 10 0.0003
440 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
441 BACTERIAL INFECTION 6 0.0003
442 NASAL DRYNESS 2 0.0003
443 SPUTUM DISCOLOURED 3 0.0003
444 ACUTE KIDNEY INJURY 48 0.0003
445 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
446 CARDIAC FLUTTER 2 0.0003
447 RESPIRATORY TRACT INFECTION 8 0.0003
448 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
449 DEAFNESS NEUROSENSORY 1 0.0003
450 DYSGRAPHIA 2 0.0003
451 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
452 RESTLESSNESS 11 0.0003
453 CARDIAC FAILURE ACUTE 2 0.0003
454 BREAST MASS 2 0.0003
455 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
456 BRONCHOPNEUMONIA 1 0.0003
457 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
458 ONYCHOCLASIS 2 0.0003
459 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
460 APHONIA 4 0.0003
461 GASTROOESOPHAGEAL REFLUX DISEASE 23 0.0003
462 HYPOACUSIS 12 0.0003
463 BACK INJURY 3 0.0003
464 FAECES SOFT 2 0.0003
465 CAROTID ARTERY OCCLUSION 1 0.0003
466 CUTANEOUS VASCULITIS 1 0.0003
467 WOUND INFECTION 3 0.0003
468 BLOOD GLUCOSE FLUCTUATION 3 0.0003
469 STAPHYLOCOCCAL INFECTION 9 0.0003
470 LIP SWELLING 9 0.0003
471 ARTHROPOD BITE 2 0.0003
472 DEAFNESS 7 0.0003
473 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
474 CHRONIC SINUSITIS 1 0.0003
475 ANHEDONIA 7 0.0003
476 IMPAIRED DRIVING ABILITY 3 0.0003
477 BLOOD COUNT ABNORMAL 4 0.0003
478 TROPONIN INCREASED 2 0.0003
479 DRUG DISPENSING ERROR 4 0.0003
480 PROCEDURAL COMPLICATION 2 0.0003
481 DRUG ADMINISTRATION ERROR 8 0.0003
482 PHARYNGEAL OEDEMA 4 0.0003
483 PAIN OF SKIN 7 0.0003
484 DYSPHONIA 15 0.0003
485 HEART RATE DECREASED 9 0.0003
486 DRUG INEFFECTIVE 331 0.0003
487 ATRIAL FLUTTER 2 0.0003
488 RHINITIS 2 0.0002
489 APPLICATION SITE DISCOLOURATION 1 0.0002
490 CEREBRAL INFARCTION 6 0.0002
491 OSTEONECROSIS 8 0.0002
492 HYPERAESTHESIA 2 0.0002
493 HAIR DISORDER 2 0.0002
494 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
495 VENTRICULAR TACHYCARDIA 4 0.0002
496 SPINAL COMPRESSION FRACTURE 2 0.0002
497 DRUG EFFECT DECREASED 13 0.0002
498 VIRAL INFECTION 8 0.0002
499 ACCIDENTAL EXPOSURE 1 0.0002
500 CONGESTIVE CARDIOMYOPATHY 1 0.0002
501 DYSPNOEA EXERTIONAL 9 0.0002
502 MOUTH ULCERATION 5 0.0002
503 INFUSION SITE ERYTHEMA 2 0.0002
504 HALLUCINATION, VISUAL 5 0.0002
505 BUNDLE BRANCH BLOCK LEFT 1 0.0002
506 COGNITIVE DISORDER 11 0.0002
507 FACIAL PARALYSIS 2 0.0002
508 JOINT INJURY 5 0.0002
509 MYDRIASIS 3 0.0002
510 SCAR 4 0.0002
511 SKIN ULCER 6 0.0002
512 BLISTER 13 0.0002
513 FAECES DISCOLOURED 5 0.0002
514 SKIN SWELLING 2 0.0002
515 CHAPPED LIPS 1 0.0002
516 NODULE 3 0.0002
517 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
518 BLOOD CREATINE INCREASED 1 0.0002
519 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
520 RESPIRATORY RATE INCREASED 2 0.0002
521 STEVENS-JOHNSON SYNDROME 5 0.0002
522 BRAIN NEOPLASM MALIGNANT 1 0.0002
523 SNEEZING 5 0.0002
524 CHROMATURIA 5 0.0002
525 PRODUCT AVAILABILITY ISSUE 5 0.0002
526 MEMORY IMPAIRMENT 30 0.0002
527 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
528 DRUG INTOLERANCE 21 0.0002
529 MUSCULOSKELETAL STIFFNESS 19 0.0002
530 FEELING COLD 6 0.0002
531 HYPERSENSITIVITY 40 0.0002
532 DYSGEUSIA 16 0.0002
533 NECK PAIN 12 0.0002
534 BLOOD URINE PRESENT 4 0.0002
535 SKIN DISORDER 7 0.0002
536 RED BLOOD CELL COUNT DECREASED 6 0.0002
537 SLEEP APNOEA SYNDROME 4 0.0002
538 PRODUCTIVE COUGH 10 0.0002
539 BALANCE DISORDER 18 0.0002
540 APHAGIA 1 0.0002
541 SINUS BRADYCARDIA 2 0.0002
542 GASTROENTERITIS 3 0.0002
543 SKIN FISSURES 4 0.0002
544 APPLICATION SITE BURN 1 0.0002
545 BLADDER DISORDER 2 0.0002
546 CORONARY ARTERY STENOSIS 1 0.0002
547 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
548 INCORRECT DOSE ADMINISTERED 45 0.0002
549 DRY THROAT 2 0.0002
550 TOOTH ABSCESS 2 0.0002
551 DEVICE RELATED INFECTION 3 0.0002
552 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
553 ANKLE FRACTURE 3 0.0002
554 POOR VENOUS ACCESS 2 0.0002
555 TOOTH LOSS 4 0.0002
556 SWOLLEN TONGUE 6 0.0002
557 ARTHRITIS 15 0.0002
558 CATATONIA 1 0.0002
559 KNEE ARTHROPLASTY 4 0.0002
560 PNEUMOTHORAX 3 0.0002
561 OSTEOARTHRITIS 8 0.0002
562 RENAL PAIN 2 0.0002
563 MIGRAINE 18 0.0002
564 NO ADVERSE EVENT 34 0.0002
565 BODY HEIGHT DECREASED 2 0.0002
566 COMPRESSION FRACTURE 1 0.0002
567 RHINORRHOEA 12 0.0002
568 SINUSITIS 19 0.0002
569 DECREASED ACTIVITY 2 0.0002
570 THROAT TIGHTNESS 5 0.0002
571 CHEILITIS 1 0.0002
572 MUSCULAR WEAKNESS 21 0.0002
573 BLOOD POTASSIUM INCREASED 3 0.0002
574 SWELLING FACE 12 0.0002
575 SKIN LACERATION 2 0.0002
576 DIABETES MELLITUS 14 0.0002
577 PRODUCT PRESCRIBING ISSUE 4 0.0002
578 PULMONARY THROMBOSIS 2 0.0002
579 ASPIRATION 2 0.0002
580 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
581 PHOTOSENSITIVITY REACTION 3 0.0002
582 DEAFNESS UNILATERAL 1 0.0002
583 CHOKING SENSATION 1 0.0002
584 WOUND 5 0.0002
585 THROAT IRRITATION 8 0.0002
586 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
587 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36 0.0002
588 MITRAL VALVE INCOMPETENCE 2 0.0002
589 MYOCARDIAL ISCHAEMIA 2 0.0002
590 MICTURITION URGENCY 2 0.0002
591 MUSCULOSKELETAL DISCOMFORT 3 0.0002
592 TINNITUS 8 0.0002
593 BLOOD URIC ACID INCREASED 1 0.0002
594 MUSCULOSKELETAL PAIN 9 0.0002
595 COUGH 48 0.0002
596 METASTASES TO LIVER 3 0.0002
597 URINARY TRACT INFECTION 29 0.0002
598 URINARY INCONTINENCE 5 0.0002
599 BLOOD IRON DECREASED 2 0.0002
600 PULMONARY EMBOLISM 16 0.0002
601 NEUROPATHY PERIPHERAL 16 0.0002
602 CHOLECYSTITIS 2 0.0002
603 HYPERLIPIDAEMIA 2 0.0002
604 OFF LABEL USE 146 0.0002
605 BLOOD PRESSURE FLUCTUATION 4 0.0002
606 HEPATITIS C 2 0.0002
607 LOCALISED INFECTION 4 0.0002
608 RESTLESS LEGS SYNDROME 3 0.0002
609 NEURALGIA 4 0.0002
610 VERTIGO 10 0.0002
611 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
612 MEDICATION ERROR 9 0.0002
613 GENERALISED OEDEMA 2 0.0002
614 CYST 2 0.0002
615 HAIR COLOUR CHANGES 2 0.0002
616 BACK PAIN 37 0.0002
617 ASTHMA 18 0.0002
618 PARAESTHESIA 25 0.0002
619 FOOT FRACTURE 3 0.0002
620 PULMONARY FIBROSIS 3 0.0002
621 DRUG PRESCRIBING ERROR 3 0.0002
622 CONTUSION 15 0.0002
623 ROTATOR CUFF SYNDROME 2 0.0002
624 INFUSION SITE PAIN 2 0.0002
625 HERNIA 3 0.0002
626 LACTIC ACIDOSIS 5 0.0002
627 PLASMA CELL MYELOMA 6 0.0002
628 PALPITATIONS 18 0.0002
629 BRADYPHRENIA 1 0.0002
630 NEPHROLITHIASIS 7 0.0002
631 ASPERGILLUS INFECTION 1 0.0002
632 ORAL CANDIDIASIS 2 0.0002
633 WHEEZING 9 0.0002
634 ANKYLOSING SPONDYLITIS 2 0.0002
635 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
636 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
637 SINUS DISORDER 3 0.0002
638 HEART RATE INCREASED 15 0.0002
639 APPETITE DISORDER 1 0.0002
640 UNDERDOSE 11 0.0002
641 UPPER LIMB FRACTURE 3 0.0002
642 FUNGAL INFECTION 5 0.0001
643 URINARY RETENTION 5 0.0001
644 CARDIAC DISORDER 14 0.0001
645 SINUS CONGESTION 2 0.0001
646 CONDITION AGGRAVATED 45 0.0001
647 ARRHYTHMIA 7 0.0001
648 OEDEMA PERIPHERAL 18 0.0001
649 LIMB INJURY 4 0.0001
650 MUSCLE SPASMS 27 0.0001
651 EPISTAXIS 11 0.0001
652 MULTIPLE SCLEROSIS 7 0.0001
653 BLOOD TESTOSTERONE DECREASED 1 0.0001
654 HOT FLUSH 11 0.0001
655 SKIN LESION 4 0.0001
656 ANAPHYLACTIC REACTION 8 0.0001
657 ORAL DISCOMFORT 2 0.0001
658 ATRIAL FIBRILLATION 14 0.0001
659 COORDINATION ABNORMAL 2 0.0001
660 MASS 2 0.0001
661 RASH MACULAR 5 0.0001
662 HYPERKALAEMIA 5 0.0001
663 BLOOD TEST ABNORMAL 2 0.0001
664 HYPERTENSION 30 0.0001
665 SINUS TACHYCARDIA 2 0.0001
666 RETCHING 3 0.0001
667 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
668 BRONCHOSPASM 2 0.0001
669 CARDIOGENIC SHOCK 2 0.0001
670 SKIN CANCER 3 0.0001
671 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
672 DEVICE DISLOCATION 6 0.0001
673 FLUID OVERLOAD 2 0.0001
674 CHEST DISCOMFORT 14 0.0001
675 ACCIDENTAL OVERDOSE 5 0.0001
676 THERAPY CESSATION 7 0.0001
677 NASAL CONGESTION 8 0.0001
678 ACUTE MYOCARDIAL INFARCTION 4 0.0001
679 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
680 PULMONARY MASS 2 0.0001
681 FATIGUE 104 0.0001
682 BONE LOSS 2 0.0001
683 BLOOD POTASSIUM DECREASED 4 0.0001
684 PRURITUS 51 0.0001
685 HYPOAESTHESIA ORAL 2 0.0001
686 DIZZINESS 66 0.0001
687 CORONARY ARTERY DISEASE 4 0.0001
688 DISCOMFORT 8 0.0001
689 ACIDOSIS 1 0.0001
690 HEADACHE 82 0.0001
691 THYROID DISORDER 2 0.0001
692 LIMB DISCOMFORT 4 0.0001
693 MUSCULOSKELETAL CHEST PAIN 2 0.0001
694 CONCUSSION 1 0.0001
695 RASH PRURITIC 7 0.0001
696 RENAL DISORDER 6 0.0001
697 LUNG INFECTION 2 0.0001
698 EJECTION FRACTION DECREASED 2 0.0001
699 APNOEA 1 0.0001
700 ACUTE MYELOID LEUKAEMIA 2 0.0001
701 SWELLING 12 0.0001
702 BONE DENSITY DECREASED 4 0.0001
703 ASTHENIA 48 0.0001
704 BLOOD ALBUMIN DECREASED 1 0.0001
705 SCIATICA 2 0.0001
706 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
707 OXYGEN SATURATION DECREASED 7 0.0001
708 CHEST PAIN 23 0.0001
709 NIGHT SWEATS 4 0.0001
710 MUSCLE TIGHTNESS 2 0.0001
711 DYSKINESIA 5 0.0001
712 PRODUCT DOSE OMISSION ISSUE 36 0.0001
713 ABNORMAL FAECES 1 0.0001
714 METASTASES TO BONE 2 0.0001
715 HERPES ZOSTER 7 0.0001
716 PNEUMONIA 39 0.0001
717 BLOOD UREA INCREASED 2 0.0001
718 ATRIAL SEPTAL DEFECT 1 0.0001
719 NASOPHARYNGITIS 22 0.0001
720 PERICARDITIS 2 0.0001
721 OROPHARYNGEAL PAIN 11 0.0001
722 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
723 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
724 INJECTION SITE SWELLING 9 0.0001
725 INFECTION 17 0.0001
726 ERYTHEMA 24 0.0001
727 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
728 CARDIAC OPERATION 1 0.0001
729 CARDIAC MURMUR 1 0.0001
730 ECZEMA 6 0.0001
731 COLD SWEAT 2 0.0001
732 HEAD DISCOMFORT 2 0.0001
733 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
734 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
735 CARDIAC FAILURE CONGESTIVE 9 0.0001
736 GALLBLADDER DISORDER 2 0.0001
737 CEREBRAL HAEMORRHAGE 4 0.0001
738 FEAR 3 0.0001
739 DYSPNOEA 63 0.0001
740 ANAL INCONTINENCE 1 0.0001
741 FREQUENT BOWEL MOVEMENTS 3 0.0001
742 BLOOD BILIRUBIN INCREASED 3 0.0001
743 GASTROENTERITIS VIRAL 2 0.0001
744 TOOTHACHE 2 0.0001
745 OSTEOMYELITIS 2 0.0001
746 PNEUMONITIS 3 0.0001
747 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
748 SKIN DISCOLOURATION 5 0.0001
749 RESPIRATORY DISTRESS 3 0.0001
750 HYPERHIDROSIS 14 0.0001
751 ABNORMAL DREAMS 3 0.0001
752 BLOOD GLUCOSE ABNORMAL 2 0.0001
753 DIVERTICULITIS 3 0.0001
754 PROCEDURAL PAIN 3 0.0001
755 BRONCHITIS 8 0.0001
756 HEPATIC STEATOSIS 2 0.0001
757 BLOOD CHOLESTEROL INCREASED 5 0.0001
758 RENAL IMPAIRMENT 9 0.0001
759 ARTERIOSCLEROSIS 1 0.0001
760 NAUSEA 84 0.0001
761 PAIN IN JAW 3 0.0001
762 ARTHRALGIA 44 0.0001
763 FRACTURE 2 0.0001
764 ABDOMINAL DISTENSION 11 0.0001
765 DYSPHAGIA 10 0.0001
766 INTENTIONAL DOSE OMISSION 3 0.0001
767 MUSCULOSKELETAL DISORDER 2 0.0001
768 PRODUCT USE IN UNAPPROVED INDICATION 26 0.0001
769 ACUTE RESPIRATORY FAILURE 2 0.0001
770 PERIPHERAL SWELLING 16 0.0001
771 ATELECTASIS 1 0.0001
772 ERUCTATION 2 0.0001
773 PLATELET COUNT DECREASED 11 0.0001
774 LIVER FUNCTION TEST ABNORMAL 3 0.0001
775 EAR PAIN 2 0.0001
776 MALAISE 45 0.0001
777 BONE PAIN 6 0.0001
778 LUNG DISORDER 5 0.0001
779 COELIAC DISEASE 1 0.0001
780 ANXIETY 29 0.0001
781 HAEMATOCRIT DECREASED 2 0.0001
782 BLOOD GLUCOSE INCREASED 19 0.0001
783 PRESCRIBED UNDERDOSE 2 0.0001
784 SPINAL FRACTURE 2 0.0001
785 ANAEMIA 19 0.0001
786 FULL BLOOD COUNT DECREASED 2 0.0001
787 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
788 EXTRA DOSE ADMINISTERED 4 0.0001
789 DRY MOUTH 8 0.0001
790 DEHYDRATION 13 0.0001
791 OSTEOPOROSIS 4 0.0001
792 ILLNESS 10 0.0001
793 DEPRESSION 22 0.0001
794 CONSTIPATION 21 0.0001
795 FEELING ABNORMAL 23 0.0001
796 NERVOUSNESS 5 0.0001
797 ROAD TRAFFIC ACCIDENT 4 0.0001
798 URTICARIA 16 0.0001
799 DECREASED APPETITE 22 0.0001
800 DEPRESSED MOOD 5 0.0001
801 CEREBROVASCULAR ACCIDENT 16 0.0001
802 GAIT DISTURBANCE 18 0.0001
803 CHILLS 11 0.0001
804 LIVER FUNCTION TEST INCREASED 2 0.0001
805 PAIN 57 0.0001
806 DISTURBANCE IN ATTENTION 5 0.0001
807 BIPOLAR DISORDER 1 0.0001
808 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
809 TREATMENT NONCOMPLIANCE 5 0.0001
810 COVID-19 16 0.0001
811 EMOTIONAL DISTRESS 11 0.0001
812 PRODUCT USE ISSUE 17 0.0001
813 ANGIOEDEMA 4 0.0001
814 ABDOMINAL PAIN 21 0.0001
815 FALL 30 0.0001
816 TOOTH DISORDER 2 0.0001
817 DIARRHOEA 58 0.0001
818 WEIGHT DECREASED 25 0.0001
819 ABDOMINAL DISCOMFORT 15 0.0001
820 GLOSSODYNIA 2 0.0001
821 GASTROINTESTINAL DISORDER 8 0.0001
822 BLOOD CALCIUM DECREASED 1 0.0001
823 FLUSHING 9 0.0001
824 HEART RATE IRREGULAR 2 0.0001
825 HAEMOGLOBIN DECREASED 9 0.0001
826 CHOLECYSTECTOMY 1 0.0001
827 GASTRIC DISORDER 3 0.0001
828 SKIN IRRITATION 4 0.0001
829 CARDIAC FAILURE 7 0.0001
830 THROMBOSIS 7 0.0001
831 SURGERY 5 0.0001
832 COVID-19 PNEUMONIA 1 0.0001
833 DISEASE RECURRENCE 4 0.0001
834 PRODUCT PRESCRIBING ERROR 2 0.0001
835 ACCIDENT 1 0.0001
836 JOINT SWELLING 10 0.0001
837 INSOMNIA 22 0.0001
838 HYPOGLYCAEMIA 4 0.0001
839 C-REACTIVE PROTEIN INCREASED 3 0.0001
840 STOMATITIS 5 0.0001
841 BURSITIS 1 0.0001
842 DRY SKIN 11 0.0001
843 PANIC ATTACK 3 0.0001
844 PRESYNCOPE 2 0.0001
845 PLEURAL EFFUSION 5 0.0001
846 DYSURIA 3 0.0001
847 ALOPECIA 16 0.0001
848 CARDIOMEGALY 1 0.0001
849 INFLUENZA 9 0.0001
850 AGEUSIA 2 0.0001
851 ACNE 6 0.0001
852 ABDOMINAL PAIN LOWER 2 0.0001
853 GASTRIC CANCER 2 0.0001
854 DRUG DOSE OMISSION 13 0.0001
855 PAIN IN EXTREMITY 23 0.0001
856 RASH 34 0.0001
857 DRUG RESISTANCE 2 0.0001
858 ANOREXIA 1 0.0001
859 HAEMATOMA 2 0.0001
860 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
861 DEEP VEIN THROMBOSIS 5 0.0001
862 BLOOD CREATININE INCREASED 5 0.0001
863 HAEMORRHAGE 8 0.0001
864 JOINT STIFFNESS 2 0.0001
865 BEDRIDDEN 1 0.0001
866 WEIGHT INCREASED 17 0.0001
867 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
868 PANCREATITIS 4 0.0001
869 ADVERSE REACTION 1 0.0001
870 EAR INFECTION 2 0.0001
871 PALLOR 2 0.0001
872 HEPATIC ENZYME INCREASED 5 0.0001
873 CORONARY ARTERY OCCLUSION 1 0.0001
874 INFLUENZA LIKE ILLNESS 6 0.0001
875 INJECTION SITE ERYTHEMA 9 0.0001
876 HAEMATOCHEZIA 4 0.0001
877 PANCYTOPENIA 4 0.0001
878 DYSPEPSIA 7 0.0001
879 SKIN EXFOLIATION 6 0.0001
880 HYPOTENSION 14 0.0001
881 PYREXIA 24 0.0001
882 PANCREATIC CARCINOMA 2 0.0001
883 ANOSMIA 1 0.0001
884 NEEDLE ISSUE 2 0.0001
885 CONFUSIONAL STATE 11 0.0001
886 ABDOMINAL PAIN UPPER 14 0.0001
887 CARDIOMYOPATHY 1 0.0001
888 HYPOAESTHESIA 10 0.0001
889 THERAPEUTIC RESPONSE DECREASED 4 0.0001
890 ILL-DEFINED DISORDER 4 0.0001
891 INJECTION SITE RASH 2 0.0001
892 EMOTIONAL DISORDER 2 0.0001
893 GYNAECOMASTIA 2 0.0001
894 BASAL CELL CARCINOMA 1 0.0001
895 VOMITING 30 0.0001
896 HEAD INJURY 2 0.0001
897 RASH ERYTHEMATOUS 3 0.0001
898 ABSCESS 1 0.0001
899 HYPOTHYROIDISM 2 0.0001
900 LOSS OF CONSCIOUSNESS 8 0.0001
901 MOVEMENT DISORDER 2 0.0001
902 INTERSTITIAL LUNG DISEASE 3 0.0001
903 BACK DISORDER 1 0.0001
904 FEBRILE NEUTROPENIA 4 0.0001
905 CYTOMEGALOVIRUS INFECTION 1 0.0001
906 COAGULOPATHY 1 0.0001
907 CELLULITIS 3 0.0001
908 TYPE 2 DIABETES MELLITUS 2 0.0001
909 CANDIDA INFECTION 1 0.0001
910 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
911 DISEASE PROGRESSION 7 0.0001
912 CIRCULATORY COLLAPSE 1 0.0001
913 DELIRIUM 2 0.0001
914 INJURY 4 0.0001
915 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
916 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
917 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
918 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
919 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
920 OEDEMA 3 0.0001
921 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
922 HYPERGLYCAEMIA 2 0.0001
923 BONE DISORDER 1 0.0001
924 RESPIRATORY FAILURE 4 0.0001
925 SEPSIS 6 0.0001
926 HEPATIC FUNCTION ABNORMAL 2 0.0001
927 TOXICITY TO VARIOUS AGENTS 9 0.0001
928 BLOOD SODIUM DECREASED 1 0.0001
929 MYALGIA 9 0.0001
930 UNEVALUABLE EVENT 4 0.0001
931 CONVULSION 3 0.0001
932 LETHARGY 3 0.0001
933 HOSPITALISATION 8 0.0001
934 MYOCARDIAL INFARCTION 9 0.0001
935 ABNORMAL BEHAVIOUR 2 0.0001
936 DISORIENTATION 2 0.0001
937 INJECTION SITE BRUISING 4 0.0001
938 SYNCOPE 5 0.0000
939 SOMNOLENCE 10 0.0000
940 INJECTION SITE PAIN 15 0.0000
941 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
942 CARDIO-RESPIRATORY ARREST 2 0.0000
943 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
944 AMNESIA 3 0.0000
945 MENTAL DISORDER 2 0.0000
946 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
947 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
948 APPLICATION SITE PAIN 1 0.0000
949 DEVICE DIFFICULT TO USE 3 0.0000
950 INFUSION RELATED REACTION 3 0.0000
951 NEOPLASM MALIGNANT 3 0.0000
952 ADVERSE EVENT 4 0.0000
953 HYPOKALAEMIA 2 0.0000
954 DEATH 37 0.0000
955 TREMOR 7 0.0000
956 SKIN BURNING SENSATION 3 0.0000
957 BLOOD GLUCOSE DECREASED 2 0.0000
958 ABASIA 1 0.0000
959 LEUKOPENIA 2 0.0000
960 FLUID RETENTION 2 0.0000
961 ANAPHYLACTIC SHOCK 1 0.0000
962 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
963 SPEECH DISORDER 2 0.0000
964 BRADYCARDIA 2 0.0000
965 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
966 PROSTATE CANCER 3 0.0000
967 ARTHROPATHY 2 0.0000
968 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
969 SEIZURE 4 0.0000
970 PRODUCT STORAGE ERROR 3 0.0000
971 ASCITES 1 0.0000
972 FEELING HOT 2 0.0000
973 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
974 DRUG INTERACTION 5 0.0000
975 CYSTITIS 1 0.0000
976 PSORIASIS 4 0.0000
977 NEUTROPENIA 4 0.0000
978 BURNING SENSATION 2 0.0000
979 SLEEP DISORDER 2 0.0000
980 OVERDOSE 6 0.0000
981 COLITIS 1 0.0000
982 INTENTIONAL PRODUCT MISUSE 2 0.0000
983 TACHYCARDIA 2 0.0000
984 COLITIS ULCERATIVE 1 0.0000
985 ADVERSE DRUG REACTION 2 0.0000
986 COMA 1 0.0000
987 COLORECTAL CANCER 1 0.0000
988 THROMBOCYTOPENIA 2 0.0000
989 RHEUMATOID ARTHRITIS 2 0.0000
990 DRUG DEPENDENCE 2 0.0000
991 CARDIAC ARREST 1 0.0000